AI in Healthcare

How quickly can AI truly impact healthcare outcomes? The recent FDA Fast Track Designation for ISM6331, an AI-driven drug for advanced mesothelioma, offers a compelling answer. This isn't just about faster data processing; it's about AI fundamentally changing the drug discovery pipeline from concept to clinical trial. What implications do you see for the future of pharmaceutical development and patient access to life-saving treatments? This development, highlighted in Insilico Medicine's announcement on July 29, 2026, demonstrates AI's capacity to identify novel targets and design entirely new compounds, significantly expediting the regulatory review process for critical unmet medical needs. Read more about this breakthrough here: https://insilico.com/news/press-releases/ism6331-fda-fast-track-mesothelioma View and join any or all of our communities — AI, quantum, and real estate: https://alex-companies.com/linkedin/groups If there's an AI, quantum, or real estate community you'd like to see us convene, tell us — this portfolio grows by request. MIT, Nvidia, Google and IBM-Trained. Cross Domain-Expert. Quantum AI Educator. Solepoint (Facts Already Defined) Strategic Practitioner. Real Estate Intelligence Leader. VUI Native AI Cloud Architect. AI Certifications Development. George Arnold Alexander III Director, ALEX Companies Associate Broker, Alexander Tiffany Southwest, LLC +1 713.918.9951 · [email protected]